Orthopedic Biomaterials Market to Reach $35.90 Billion By 2030

Orthopedic Biomaterials Market Growth & Trends

The global orthopedic biomaterials market size is expected to reach USD 35.90 billion by 2030, growing at a CAGR of 7.5% from 2024 to 2030, according to a new study by Grand View Research, Inc. Several key factors, including the increasing prevalence of orthopedic conditions and advancements in biomaterial technology, drive the market. Due to an aging population and active lifestyles, the rising incidence of musculoskeletal disorders, such as osteoarthritis and fractures, is significantly boosting the demand for orthopedic biomaterials. Moreover, technological innovations, such as the development of advanced composites and smart biomaterials, enhance the performance and integration of these materials in orthopedic implants and prosthetics, thereby expanding their application and effectiveness.

The increasing prevalence of musculoskeletal disorders and chronic skeletal conditions is fueling the market growth.According to the 2023 HSE Report, approximately 473,000 workers in Great Britain experienced work-related musculoskeletal disorders (MSDs), resulting in the loss of around 6.6 million working days. These disorders accounted for 27% of all work-related ill health cases. The growing focus on minimally invasive surgical techniques also contributes to market growth. Orthopedic biomaterials that support less invasive procedures, such as bioresorbable materials and improved implant coatings, are gaining traction due to their potential to reduce recovery times and complications. The increased investment in research and development, rising healthcare expenditures, and awareness about advanced orthopedic solutions further propels the market, making it a dynamic and rapidly evolving sector.

The rising prevalence of trauma cases is also driving the demand for orthopedic biomaterials. According to an article published by WHO in June 2022, road accidents kill approximately 1.3 million people worldwide, and approximately 20 to 50 million people suffer from non-fatal injuries. These injuries often require orthopedic surgery, leading to an increased demand for orthopedic biomaterials.

 Request a free sample copy or view report summary: Orthopedic Biomaterials Market Report

Orthopedic Biomaterials Market Report Highlights

• By material, ceramics & bioactive glass segment accounted for the highest revenue share in 2023. The growth is attributed to the increased adoption of ceramics in the repair of hard tissues in various procedures

• By application, orthopedic implants segment accounted for the largest market share in 2023. The growth is owed to the rising incidences of disc degenerative conditions and bone fractures coupled with increasing trauma case

• In 2023, North America dominated the overall market with a revenue share of 36.2% due to the rising adoption of advanced products for bone void filling and implant load-bearing purposes

Orthopedic Biomaterials Market Segmentation

Grand View Research has segmented the global orthopedic biomaterials market based on material, application, and region:

Orthopedic Biomaterials Material Outlook (Revenue, USD Million, 2018 - 2030­)

• Ceramics & Bioactive Glass Biomaterials

• Polymers Biomaterials

• Calcium Phosphate Cements

• Metal Biomaterials

• Composites

Orthopedic Biomaterials Application Outlook (Revenue, USD Million, 2018 - 2030­)

• Orthopedic Implants

• Joint Replacement/reconstruction

• Orthobiologics

• Visco Supplementation

• Bio-resorbable Tissue Fixation

Orthopedic Biomaterials Regional Outlook (Revenue, USD Million, 2018 - 2030­)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Norway

  • Sweden

  • Denmark

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Orthopedic Biomaterials Market

• DSM Biomedical

• Evonik industries AG

• Stryker Corp.

• Depuy Synthes Inc.

• Zimmer Biomet

• Invibo Ltd.

• Globus Medical

• Exactech, Inc.

• Matexcel

• AdvanSource

• Biomaterials Corp.

• CAM Bioceramics B.V.

• Heraeus Holding